{
 "PrintNo":"S6332","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-04-14T15:37:34.703026Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-04-14","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1500,"Name":"Samra Brouk","Short":"BROUK"}],
 "Title":"Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology",
 "Summary":"Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง273, Pub Health L; add ยง3216-a, Ins L",
 "ActClause":"AN ACT to amend the public health law and the insurance law, in relation to the use of abuse-deterrent technology for opioids as a mechanism for reducing abuse and diversion of opioid drugs",
 "SameAsPrintNo":"A62-2023","PreviousVersions":["S6397-2019","S4532-2021"]
}